Director, Clinical Sciences, Oncology

Johnson & Johnson Johnson & Johnson · Pharma · Spring House, PA +2

Director, Clinical Sciences, Oncology role at Johnson & Johnson focused on designing, planning, and managing complex clinical trials in oncology. This role involves contributing to clinical development strategy, protocol development, data monitoring, and ensuring compliance with regulatory standards for health authority submissions. It requires collaboration with cross-functional teams, investigators, and external partners, and may involve managing direct reports.

What you'd actually do

  1. Drive clinical development strategy, contribute to the development of other study-related materials (e.g. ADP, SAP, CSR outputs, case report forms, operational plans) and provide clinical representation for study-related review committees (e.g., first in human committee, protocol review committee).
  2. Lead the execution of clinical trial protocols within the clinical development program, ensuring compliance with scientific, organizational, and regulatory standards.
  3. Oversee end-to-end delivery of clinical trial protocols/programs, including study design, initiation, medical safety data monitoring, data dissemination, and closeout activities.
  4. Manage and coordinate activities with internal functional partners and external partners to ensure timely scientific and clinical execution of clinical studies.
  5. Maintain the quality and integrity of clinical data critical to the evaluation of study endpoints. Interact and collaborate with investigators and study teams during the conduct of the trial(s).

Skills

Required

  • Clinical trial design and execution
  • Clinical development strategy
  • Protocol development
  • Medical data monitoring and interpretation
  • Regulatory compliance
  • Cross-functional team leadership
  • Stakeholder management
  • Oncology therapeutic area knowledge

Nice to have

  • Mentorship and training
  • Process improvement identification and implementation
  • Innovative research methods

What the JD emphasized

  • regulatory standards
  • medical data monitoring
  • health authority submissions